{
  "id": "tinnitus-evaluation",
  "title": "Tinnitus Evaluation",
  "version": "1.1",
  "icd10": [
    "** H93.19 (Tinnitus",
    "unspecified ear)",
    "H93.11 (Tinnitus",
    "right ear)",
    "H93.12 (Tinnitus",
    "left ear)",
    "H93.A9 (Pulsatile tinnitus",
    "unspecified ear)",
    "H93.A1 (Pulsatile tinnitus",
    "right ear)",
    "H93.A2 (Pulsatile tinnitus",
    "left ear)",
    "H93.A3 (Pulsatile tinnitus",
    "bilateral)",
    "H93.19 (Tinnitus",
    "unspecified)",
    "R42 (Dizziness and giddiness — when co-occurring)",
    "H90.5 (Unspecified sensorineural hearing loss)",
    "D33.3 (Benign neoplasm of cranial nerves — vestibular schwannoma)"
  ],
  "scope": "** Neurological evaluation and management of tinnitus in adults. Covers classification (pulsatile vs. non-pulsatile, subjective vs. objective), identification of red flags (unilateral tinnitus, pulsatile tinnitus, associated hearing loss, focal neurological deficits), evaluation for vascular causes (dural arteriovenous fistula, carotid stenosis/dissection, IIH, glomus tumors), cerebellopontine angle tumors (vestibular schwannoma/acoustic neuroma), audiometric evaluation, MRI/MRA indications, and management including CBT for tinnitus, sound therapy, and pharmacotherapy. Excludes primary otologic management of cerumen impaction, otitis media, otosclerosis, and cochlear implant evaluation (ENT-managed). Excludes tinnitus in pediatric populations.",
  "notes": [],
  "sections": {
    "Laboratory Workup": {
      "Essential/Core Labs": [
        {
          "item": "CBC (CPT 85025)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Anemia can cause pulsatile tinnitus (high-output state); polycythemia (hyperviscosity); infection if otitis suspected",
          "target": "Normal; anemia (Hgb <10) — correct and reassess; elevated WBC — infection"
        },
        {
          "item": "CMP (CPT 80053)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Electrolyte abnormalities; renal dysfunction (uremia can cause tinnitus); baseline metabolic assessment",
          "target": "Normal; BUN/Cr elevation — renal evaluation; hyponatremia"
        },
        {
          "item": "TSH (CPT 84443)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Hyperthyroidism causes pulsatile tinnitus (high-output state); hypothyroidism associated with sensorineural hearing loss",
          "target": "Normal; hyperthyroidism — endocrine referral; hypothyroidism — treat and reassess hearing"
        },
        {
          "item": "Blood glucose / HbA1c (CPT 82947 / 83036)",
          "ED": "ROUTINE",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Diabetes is risk factor for sensorineural hearing loss and small vessel disease; diabetic neuropathy affecting cochlear nerve; relevant for sudden SNHL workup",
          "target": "Fasting glucose 70-100; HbA1c <7.0%"
        },
        {
          "item": "Lipid panel (CPT 80061)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Vascular risk factor assessment if pulsatile tinnitus or vascular cause suspected; dyslipidemia associated with sensorineural hearing loss",
          "target": "LDL <100; total cholesterol <200; dyslipidemia — treatment"
        }
      ],
      "Extended Workup": [
        {
          "item": "ESR (CPT 85652) / CRP (CPT 86140)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Temporal arteritis (pulsatile tinnitus in elderly); vasculitis; autoimmune inner ear disease",
          "target": "Normal; elevated — evaluate for GCA in >50 yo, autoimmune SNHL"
        },
        {
          "item": "ANA (CPT 86235)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Autoimmune inner ear disease (AIED); systemic lupus; vasculitis affecting cochlea",
          "target": "Negative; positive — autoimmune workup"
        },
        {
          "item": "RPR / VDRL (CPT 86592)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Otosyphilis can present as tinnitus and hearing loss; especially if bilateral asymmetric SNHL",
          "target": "Negative; reactive — FTA-ABS confirmation, treatment"
        },
        {
          "item": "Vitamin B12 (CPT 82607)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "B12 deficiency associated with tinnitus and sensorineural hearing loss",
          "target": ">300 pg/mL; low — supplementation"
        },
        {
          "item": "Ferritin / Iron studies (CPT 82728 / 83540)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Iron deficiency anemia is common cause of pulsatile tinnitus (high-output state); even without frank anemia",
          "target": "Ferritin >50; iron-deficient — supplementation; pulsatile tinnitus may resolve"
        },
        {
          "item": "Zinc level (CPT 84630)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Zinc deficiency has been associated with tinnitus in some studies; cochlear function",
          "target": "Normal; low — supplementation trial"
        },
        {
          "item": "Coagulation studies (PT/INR, PTT) (CPT 85610 / 85730)",
          "ED": "STAT",
          "HOSP": "ROUTINE",
          "OPD": "-",
          "ICU": "-",
          "rationale": "If cerebral venous sinus thrombosis suspected (pulsatile tinnitus, headache, papilledema)",
          "target": "Normal; prolonged — evaluate coagulopathy"
        }
      ],
      "Rare/Specialized": [
        {
          "item": "FTA-ABS (CPT 86780)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Confirmatory for syphilis if RPR positive; otosyphilis diagnosis",
          "target": "Negative; positive — penicillin treatment"
        },
        {
          "item": "Lyme serology (CPT 86618)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Lyme neuroborreliosis can cause cranial neuropathies and hearing loss in endemic areas",
          "target": "Negative; positive — Western blot confirmation"
        },
        {
          "item": "Anti-cochlear antibodies / HSP-70 antibodies",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Autoimmune inner ear disease if bilateral progressive SNHL with tinnitus; responds to steroids",
          "target": "Negative; positive — steroid trial for AIED"
        },
        {
          "item": "Paraneoplastic antibody panel",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "Rare; paraneoplastic cochlear/vestibular degeneration; anti-Hu, anti-CRMP5",
          "target": "Negative; positive — malignancy search"
        },
        {
          "item": "CSF analysis (CPT 89050, 89051)",
          "ED": "-",
          "HOSP": "EXT",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "If IIH suspected (opening pressure); infectious/inflammatory cause; leptomeningeal disease; neurosyphilis confirmation",
          "target": "Opening pressure >25 cm H2O — IIH; pleocytosis — infection/inflammation; positive VDRL — neurosyphilis"
        },
        {
          "item": "Hypercoagulability panel",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-",
          "rationale": "If cerebral venous thrombosis suspected as cause of pulsatile tinnitus",
          "target": "Normal; abnormal — anticoagulation; CVT workup"
        }
      ],
      "Lumbar Puncture": [
        {
          "item": "LP with opening pressure (CPT 62270)",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "**Indicated if IIH suspected**: Pulsatile tinnitus + headache + papilledema (especially in young obese female); also if CSF infection or leptomeningeal disease suspected; **Measure opening pressure** in lateral decubitus position",
          "target": "Opening pressure >25 cm H2O — IIH; normal CSF composition in IIH; pleocytosis — infection; positive cytology — leptomeningeal disease; elevated protein — inflammation",
          "contraindications": "Mass lesion on imaging (perform MRI first); coagulopathy; anticoagulation; skin infection at LP site"
        }
      ]
    },
    "Imaging & Studies": {
      "Essential/First-line": [
        {
          "item": "**Comprehensive audiometry** (CPT 92557) with tympanometry (CPT 92550)",
          "ED": "-",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "**First-line for ALL tinnitus patients**; pure tone audiometry, speech discrimination, tympanometry; identifies type and degree of hearing loss; essential for determining etiology",
          "target": "Sensorineural hearing loss (SNHL) — cochlear vs. retrocochlear; conductive hearing loss (CHL) — middle ear pathology; asymmetric SNHL — MRI for vestibular schwannoma; normal — reassuring but does not exclude pathology",
          "contraindications": "Patient cooperation required"
        },
        {
          "item": "**MRI brain and IACs (internal auditory canals) with gadolinium** (CPT 70553)",
          "ED": "-",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "**Essential if**: Unilateral or asymmetric tinnitus; unilateral or asymmetric SNHL; pulsatile tinnitus (to evaluate for vascular malformation or CPA mass); focal neurological deficits; **Gold standard** for vestibular schwannoma, CPA tumors, meningioma, demyelination",
          "target": "Vestibular schwannoma (enhancing mass in IAC/CPA); meningioma; dural AVF; brainstem lesion; MS plaque; cholesteatoma; leptomeningeal disease",
          "contraindications": "MRI-incompatible implants; severe claustrophobia; GFR <30 (gadolinium contraindication)"
        },
        {
          "item": "**Otoscopic examination**",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "**Bedside exam for ALL patients**; evaluate for cerumen impaction, tympanic membrane perforation, middle ear effusion, glomus tumor (visible as red/blue mass behind TM), cholesteatoma",
          "target": "Cerumen impaction — removal; retrotympanic mass (glomus tumor, aberrant carotid, high jugular bulb); TM perforation; middle ear effusion",
          "contraindications": "None"
        },
        {
          "item": "**Auscultation of head, neck, periauricular region**",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "**Critical for pulsatile tinnitus**; listen over mastoid, periauricular, orbits, and neck for bruit; detect objective tinnitus from vascular lesion (dural AVF, carotid stenosis, glomus tumor)",
          "target": "Bruit present — vascular imaging (MRA/CTA); no bruit does NOT exclude vascular cause",
          "contraindications": "None"
        }
      ],
      "Extended": [
        {
          "item": "**MRA head** (CPT 70544) **and neck** (CPT 70547)",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "**Pulsatile tinnitus workup**; evaluates for dural AVF, arterial stenosis/dissection, fibromuscular dysplasia, vertebral/carotid stenosis, aneurysm; use CTA if MRA not available",
          "target": "Dural AVF (early venous filling); carotid stenosis; carotid/vertebral dissection; fibromuscular dysplasia; aneurysm; aberrant vasculature",
          "contraindications": "MRA: same as MRI; CTA (CPT 70496/70498): contrast allergy, renal impairment"
        },
        {
          "item": "**CT temporal bones** (CPT 70480) without contrast",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "**Evaluate bony anatomy**; superior semicircular canal dehiscence (can cause pulsatile tinnitus); glomus jugulare/tympanicum; otosclerosis; cholesteatoma; aberrant carotid artery; high jugular bulb; tegmen defect",
          "target": "Glomus tumor (permeative bone destruction); canal dehiscence; otosclerosis; temporal bone fracture; aberrant carotid",
          "contraindications": "Radiation exposure (low)"
        },
        {
          "item": "**CTA head and neck** (CPT 70496 / 70498)",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "Alternative or complement to MRA for pulsatile tinnitus; better spatial resolution for some vascular lesions; faster acquisition in ED; evaluates for dural AVF, carotid stenosis, dissection, glomus tumor",
          "target": "Dural AVF; stenosis; dissection; glomus tumor vascularity; fibromuscular dysplasia",
          "contraindications": "Contrast allergy; renal impairment; radiation"
        },
        {
          "item": "**Carotid duplex ultrasound** (CPT 93880)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "Non-invasive screening for carotid stenosis if pulsatile tinnitus; can detect FMD in some cases; identifies high-flow states",
          "target": "Carotid stenosis; plaque; FMD (string of beads); flow abnormalities",
          "contraindications": "None"
        },
        {
          "item": "**Fundoscopic exam / OCT**",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "**Evaluate for papilledema** if pulsatile tinnitus (IIH); bilateral papilledema in young obese female with pulsatile tinnitus — IIH until proven otherwise",
          "target": "Papilledema — measure opening pressure (LP); IIH; venous sinus thrombosis",
          "contraindications": "Pupillary dilation for detailed exam"
        },
        {
          "item": "**MR venography (MRV)** (CPT 70547)",
          "ED": "-",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "If IIH or cerebral venous sinus thrombosis suspected; evaluates venous sinus patency; transverse sinus stenosis (common in IIH and common cause of pulsatile tinnitus)",
          "target": "Venous sinus thrombosis; transverse sinus stenosis (bilateral or unilateral); venous outflow obstruction",
          "contraindications": "Same as MRI"
        }
      ],
      "Rare/Specialized": [
        {
          "item": "**Cerebral angiography (DSA)** (CPT 36224)",
          "ED": "-",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "**Gold standard for dural AVF**; obtain when MRA/CTA suggestive but inconclusive; preoperative planning for AVF embolization or glomus tumor; evaluates venous drainage patterns",
          "target": "Dural AVF (early venous filling, fistula site, venous drainage pattern); glomus tumor blood supply; vascular anatomy for embolization planning",
          "contraindications": "Invasive (stroke risk ~0.5%); contrast allergy; renal impairment; coagulopathy"
        },
        {
          "item": "**Videonystagmography (VNG)** (CPT 92540)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "If vestibular symptoms accompany tinnitus; evaluate vestibular function; caloric testing for unilateral vestibular hypofunction",
          "target": "Unilateral weakness (peripheral vestibular lesion); central patterns",
          "contraindications": "Perforated TM (water calorics)"
        },
        {
          "item": "**Auditory brainstem response (ABR)** (CPT 92585)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "If retrocochlear pathology suspected and MRI contraindicated; screening for vestibular schwannoma when MRI not possible; interaural latency differences",
          "target": "Prolonged wave I-III or I-V interpeak latency (retrocochlear lesion); absent waves",
          "contraindications": "Requires patient cooperation; less sensitive than MRI"
        },
        {
          "item": "**VEMP (vestibular evoked myogenic potentials)** (CPT 92517)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "If superior semicircular canal dehiscence suspected (pulsatile tinnitus, autophony, bone conduction hyperacusis); tests saccule/utricle",
          "target": "Reduced threshold on cVEMP/oVEMP — canal dehiscence",
          "contraindications": "Hearing loss affects testing"
        },
        {
          "item": "**OAE (otoacoustic emissions)** (CPT 92587)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "Assess outer hair cell function; normal OAEs with abnormal audiogram suggest retrocochlear pathology; helps differentiate cochlear vs. neural",
          "target": "Present OAEs with abnormal ABR — auditory neuropathy/retrocochlear; absent OAEs — cochlear damage",
          "contraindications": "Middle ear pathology affects results"
        },
        {
          "item": "**Temporal bone CT angiography**",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-",
          "timing": "Specialized for aberrant carotid artery, dehiscent jugular bulb, or persistent stapedial artery causing pulsatile tinnitus",
          "target": "Aberrant vascular anatomy; dehiscent jugular bulb; persistent stapedial artery",
          "contraindications": "Radiation; contrast"
        }
      ]
    },
    "Treatment": {
      "Acute/Emergent Treatment": [
        {
          "item": "**Treat underlying cause**",
          "route": "-",
          "indication": "All tinnitus with identifiable etiology",
          "dosing": {
            "doseOptions": [
              {
                "text": "-",
                "orderSentence": "**Treat underlying cause** - -"
              }
            ],
            "route": "-",
            "instructions": "**Priority is identifying and treating the underlying cause**: Cerumen removal (impaction); antibiotics for otitis; correct anemia; treat hyperthyroidism; discontinue ototoxic medications; manage IIH; refer for vascular intervention (dural AVF embolization, carotid endarterectomy)",
            "orderSentence": "**Treat underlying cause** - -"
          },
          "contraindications": "-",
          "monitoring": "Tinnitus is a symptom, not a diagnosis; treatment of underlying cause resolves tinnitus completely in many cases",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "**Discontinue/reduce ototoxic medications**",
          "route": "-",
          "indication": "All tinnitus patients on ototoxic drugs",
          "dosing": {
            "doseOptions": [
              {
                "text": "-",
                "orderSentence": "**Discontinue/reduce ototoxic medications** - -"
              }
            ],
            "route": "-",
            "instructions": "**Review medication list**: High-dose aspirin (>2g/day), aminoglycosides, loop diuretics (furosemide), cisplatin, quinine, vancomycin, erythromycin; reduce dose or substitute when possible",
            "orderSentence": "**Discontinue/reduce ototoxic medications** - -"
          },
          "contraindications": "When medication is essential and no alternative exists",
          "monitoring": "Ototoxic medications are a common reversible cause; [Cianfrone et al. (2011)](https://pubmed.ncbi.nlm.nih.gov/21590473/): medication review is first step",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "**IV dexamethasone** (sudden SNHL with tinnitus)",
          "route": "IV",
          "indication": "Sudden sensorineural hearing loss with tinnitus",
          "dosing": {
            "doseOptions": [
              {
                "text": "10 mg",
                "orderSentence": "**IV dexamethasone** (sudden SNHL with tinnitus) 10 mg IV"
              }
            ],
            "route": "IV",
            "instructions": "**Sudden SNHL is otologic emergency**: Dexamethasone 10 mg IV then transition to oral prednisone 1 mg/kg/day (max 60 mg) x 14 days with taper; OR methylprednisolone 48 mg daily x 14 days; start within 72 hours for best outcomes; ENT urgent referral",
            "orderSentence": "**IV dexamethasone** (sudden SNHL with tinnitus) 10 mg IV"
          },
          "contraindications": "Active infection (relative); uncontrolled diabetes; GI bleed",
          "monitoring": "Blood glucose monitoring every 6 hours while on steroids; [Chandrasekhar et al. (2019)](https://pubmed.ncbi.nlm.nih.gov/31369359/): AAO-HNS guideline recommends steroids within 2 weeks of sudden SNHL onset; earlier is better",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "URGENT",
          "ICU": "-"
        },
        {
          "item": "**Acetazolamide** (IIH-related pulsatile tinnitus)",
          "route": "PO",
          "indication": "Pulsatile tinnitus due to IIH",
          "dosing": {
            "doseOptions": [
              {
                "text": "500 mg",
                "orderSentence": "**Acetazolamide** (IIH-related pulsatile tinnitus) 500 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Acetazolamide 250-500 mg PO BID, titrate up to 1g BID as tolerated; monitor electrolytes; reduces CSF production; can dramatically improve pulsatile tinnitus in IIH",
            "orderSentence": "**Acetazolamide** (IIH-related pulsatile tinnitus) 500 mg PO"
          },
          "contraindications": "Sulfa allergy; hepatic insufficiency; hypokalemia; metabolic acidosis",
          "monitoring": "Electrolytes (potassium, bicarbonate) weekly x 4 weeks, then monthly; renal function; paresthesias (common, benign); [NORDIC Idiopathic Intracranial Hypertension Study Group (2014)](https://pubmed.ncbi.nlm.nih.gov/24687293/): acetazolamide effective for IIH",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Disease-Specific Treatment": [
        {
          "item": "**Cognitive behavioral therapy (CBT) for tinnitus**",
          "route": "-",
          "indication": "Non-pulsatile tinnitus with distress, anxiety, insomnia, or functional impairment",
          "dosing": {
            "doseOptions": [
              {
                "text": "-",
                "orderSentence": "**Cognitive behavioral therapy (CBT) for tinnitus** - -"
              }
            ],
            "route": "-",
            "instructions": "**First-line evidence-based therapy**: 8-20 sessions of CBT adapted for tinnitus; addresses catastrophic thinking, hypervigilance, emotional response to tinnitus; reduces tinnitus distress, improves sleep and function; does NOT eliminate tinnitus but reduces impact",
            "orderSentence": "**Cognitive behavioral therapy (CBT) for tinnitus** - -"
          },
          "contraindications": "None",
          "monitoring": "Track TFI/THI scores every 4-6 sessions; [Cima et al. (2012)](https://pubmed.ncbi.nlm.nih.gov/22927685/): RCT demonstrated CBT significantly reduces tinnitus severity and improves quality of life; [Cochrane review (2020)](https://pubmed.ncbi.nlm.nih.gov/33264419/): CBT is most evidence-supported therapy",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "**Sound therapy / masking**",
          "route": "-",
          "indication": "All bothersome non-pulsatile tinnitus",
          "dosing": {
            "doseOptions": [
              {
                "text": "-",
                "orderSentence": "**Sound therapy / masking** - -"
              }
            ],
            "route": "-",
            "instructions": "**Options**: Background sound enrichment (fan, white noise, nature sounds); ear-level sound generators; combination hearing aid + sound generator; Notch therapy (tailor-made notched music); smartphone apps (e.g., Oto, ReSound Relief); avoid silence",
            "orderSentence": "**Sound therapy / masking** - -"
          },
          "contraindications": "None",
          "monitoring": "Partial or complete masking reduces tinnitus perception; [Hobson et al. (2012)](https://pubmed.ncbi.nlm.nih.gov/23152232/): Cochrane review — limited evidence but widely recommended as adjunct; safe and well tolerated",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "**Tinnitus retraining therapy (TRT)**",
          "route": "-",
          "indication": "Chronic bothersome non-pulsatile tinnitus",
          "dosing": {
            "doseOptions": [
              {
                "text": "-",
                "orderSentence": "**Tinnitus retraining therapy (TRT)** - -"
              }
            ],
            "route": "-",
            "instructions": "**Combined counseling + sound therapy**: Directive counseling (neurophysiological model) + low-level broadband sound generators worn 6-8h/day; goal is habituation (tinnitus perceived but not bothersome); requires 12-24 months",
            "orderSentence": "**Tinnitus retraining therapy (TRT)** - -"
          },
          "contraindications": "Requires patient commitment and trained provider",
          "monitoring": "Clinical improvement in 70-80%; [Jastreboff & Jastreboff (2000)](https://pubmed.ncbi.nlm.nih.gov/10768108/): established protocol; evidence is moderate",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "**Hearing aids**",
          "route": "-",
          "indication": "Tinnitus with coexisting hearing loss",
          "dosing": {
            "doseOptions": [
              {
                "text": "-",
                "orderSentence": "**Hearing aids** - -"
              }
            ],
            "route": "-",
            "instructions": "**If hearing loss present**: Amplification reduces tinnitus perception by enriching auditory input; modern hearing aids include tinnitus masking programs; bilateral fitting preferred for bilateral loss; trial period recommended",
            "orderSentence": "**Hearing aids** - -"
          },
          "contraindications": "Profound hearing loss (cochlear implant evaluation instead)",
          "monitoring": "[Shekhawat et al. (2013)](https://pubmed.ncbi.nlm.nih.gov/24045571/): hearing aids improve tinnitus in majority of patients with hearing loss; offer to all eligible patients",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "**Acceptance and commitment therapy (ACT)**",
          "route": "-",
          "indication": "Alternative to CBT; tinnitus-related distress",
          "dosing": {
            "doseOptions": [
              {
                "text": "-",
                "orderSentence": "**Acceptance and commitment therapy (ACT)** - -"
              }
            ],
            "route": "-",
            "instructions": "Mindfulness-based approach; acceptance of tinnitus rather than control; values-driven action; emerging evidence supports efficacy",
            "orderSentence": "**Acceptance and commitment therapy (ACT)** - -"
          },
          "contraindications": "None",
          "monitoring": "Track TFI/THI scores; [Westin et al. (2011)](https://pubmed.ncbi.nlm.nih.gov/21849527/): ACT comparable to CBT for tinnitus distress reduction",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Medications to AVOID or Use with Caution": [
        {
          "item": "**Aminoglycosides** (gentamicin, tobramycin, amikacin)",
          "route": "IV/IM",
          "indication": "Ototoxic; dose-dependent cochlear and vestibular toxicity; can worsen tinnitus permanently",
          "dosing": {
            "doseOptions": [
              {
                "text": "-",
                "orderSentence": "**Aminoglycosides** (gentamicin, tobramycin, amikacin) - IV/IM"
              }
            ],
            "route": "IV/IM",
            "instructions": "AVOID in tinnitus patients unless no alternative exists; if essential, use once-daily dosing to reduce ototoxicity",
            "orderSentence": "**Aminoglycosides** (gentamicin, tobramycin, amikacin) - IV/IM"
          },
          "contraindications": "Tinnitus or pre-existing hearing loss (relative); renal impairment increases risk",
          "monitoring": "Drug levels (trough <1 for gentamicin); serial audiometry if prolonged course",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "**High-dose aspirin** (>2 g/day)",
          "route": "PO",
          "indication": "Dose-dependent tinnitus; reversible with dose reduction; salicylate toxicity",
          "dosing": {
            "doseOptions": [
              {
                "text": "-",
                "orderSentence": "**High-dose aspirin** (>2 g/day) - PO"
              }
            ],
            "route": "PO",
            "instructions": "AVOID doses >2 g/day; tinnitus usually resolves within 24-48h of dose reduction; low-dose aspirin (81-325 mg) is safe",
            "orderSentence": "**High-dose aspirin** (>2 g/day) - PO"
          },
          "contraindications": "Pre-existing tinnitus at high doses",
          "monitoring": "Salicylate level if toxicity suspected; reduce dose if tinnitus develops",
          "ED": "ROUTINE",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "**Loop diuretics** (furosemide, ethacrynic acid)",
          "route": "IV/PO",
          "indication": "Ototoxic, especially IV high-dose or in renal impairment; usually reversible",
          "dosing": {
            "doseOptions": [
              {
                "text": "-",
                "orderSentence": "**Loop diuretics** (furosemide, ethacrynic acid) - IV/PO"
              }
            ],
            "route": "IV/PO",
            "instructions": "Use lowest effective dose; avoid rapid IV bolus; ethacrynic acid more ototoxic than furosemide",
            "orderSentence": "**Loop diuretics** (furosemide, ethacrynic acid) - IV/PO"
          },
          "contraindications": "Pre-existing hearing loss with high doses (relative)",
          "monitoring": "Monitor hearing; use lowest effective dose; avoid IV bolus",
          "ED": "ROUTINE",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "**Cisplatin and carboplatin**",
          "route": "IV",
          "indication": "Dose-dependent irreversible cochlear toxicity; high-frequency SNHL and tinnitus",
          "dosing": {
            "doseOptions": [
              {
                "text": "-",
                "orderSentence": "**Cisplatin and carboplatin** - IV"
              }
            ],
            "route": "IV",
            "instructions": "Irreversible ototoxicity; no proven otoprotectant; cisplatin more ototoxic than carboplatin",
            "orderSentence": "**Cisplatin and carboplatin** - IV"
          },
          "contraindications": "Pre-existing hearing loss (dose modification)",
          "monitoring": "Baseline and serial audiometry during treatment; monitor cumulative dose",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "**Quinine and chloroquine**",
          "route": "PO",
          "indication": "Cinchonism (tinnitus, hearing loss, vertigo); usually reversible",
          "dosing": {
            "doseOptions": [
              {
                "text": "-",
                "orderSentence": "**Quinine and chloroquine** - PO"
              }
            ],
            "route": "PO",
            "instructions": "Reversible ototoxicity; reduce dose if tinnitus develops; hydroxychloroquine lower risk",
            "orderSentence": "**Quinine and chloroquine** - PO"
          },
          "contraindications": "Pre-existing tinnitus at therapeutic doses",
          "monitoring": "Monitor for tinnitus onset; reduce dose if symptoms develop",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "**Benzodiazepines (chronic use)**",
          "route": "PO",
          "indication": "Temporary relief but dependence risk; does not address underlying cause; rebound tinnitus on withdrawal",
          "dosing": {
            "doseOptions": [
              {
                "text": "-",
                "orderSentence": "**Benzodiazepines (chronic use)** - PO"
              }
            ],
            "route": "PO",
            "instructions": "Short-term use only if severe acute distress; transition to CBT/SSRI for long-term management; avoid chronic use",
            "orderSentence": "**Benzodiazepines (chronic use)** - PO"
          },
          "contraindications": "Dependence risk; respiratory depression; elderly (fall risk)",
          "monitoring": "Limit to 2-4 weeks; plan transition to non-benzodiazepine therapy",
          "ED": "ROUTINE",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ]
    },
    "Other Recommendations": {
      "Referrals & Consults": [
        {
          "item": "Classify tinnitus type (pulsatile vs. non-pulsatile) at initial encounter; pulsatile tinnitus requires vascular workup; ask if pulse-synchronous (check radial pulse simultaneously)",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Perform otoscopic exam on ALL patients; assess for cerumen impaction, TM abnormality, retrotympanic mass, cholesteatoma; low-cost, high-yield",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Audiology referral for comprehensive audiometry; ALL tinnitus patients require audiometry; asymmetric hearing loss triggers MRI",
          "ED": "-",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Review ALL medications for ototoxicity; aspirin, NSAIDs, aminoglycosides, loop diuretics, chemotherapeutics; discontinue or substitute when possible",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Neurology consultation if focal neurological deficits; pulsatile tinnitus with papilledema (IIH); suspected CPA mass; suspected dural AVF; diagnostic uncertainty",
          "ED": "-",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "ENT / Otolaryngology referral for ALL patients with unilateral tinnitus; hearing loss; failed initial management; hearing aid evaluation; intratympanic therapy",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Fundoscopic exam for pulsatile tinnitus to evaluate for papilledema; IIH presents with pulsatile tinnitus + headache + papilledema; tinnitus can be the presenting symptom",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Mental health screening (PHQ-9, GAD-7) for ALL tinnitus patients; tinnitus strongly associated with anxiety, depression, insomnia; tinnitus distress correlates more with psychological state than tinnitus loudness",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Neurovascular surgery consultation if dural AVF, glomus tumor, or high-grade carotid stenosis identified; multidisciplinary treatment planning",
          "ED": "-",
          "HOSP": "URGENT",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Skull base surgery / neurotology referral if vestibular schwannoma identified; multidisciplinary discussion (observation vs. SRS vs. surgery)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Patient Instructions": [
        {
          "item": "**Use sound enrichment at all times, especially at bedtime**: Use a fan, white noise machine, nature sounds, or smartphone app (Oto, ReSound Relief); avoid silence as it amplifies tinnitus perception",
          "ED": "ROUTINE",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "**Return to ED immediately** if sudden hearing loss in one or both ears, new weakness or numbness, severe new headache, vision changes, or worsening pulsatile tinnitus with headache — these require urgent evaluation",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE"
        },
        {
          "item": "**Protect hearing from noise exposure**: Wear earplugs or noise-cancelling headphones in loud environments (concerts, power tools, machinery); avoid prolonged headphone use at high volumes; noise exposure worsens tinnitus permanently",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "**Do NOT stop prescribed medications** (aspirin, acetazolamide, antidepressants) without consulting your neurologist; abrupt discontinuation can worsen symptoms or cause withdrawal effects",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "**Limit caffeine and alcohol** as both can temporarily worsen tinnitus perception; monitor personal triggers and adjust intake accordingly",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "**Report new symptoms promptly**: New facial weakness or numbness, worsening hearing, new vertigo, or change in tinnitus character (non-pulsatile becoming pulsatile) warrants re-evaluation",
          "ED": "ROUTINE",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "**Engage with recommended therapy**: CBT for tinnitus requires 8-20 sessions for full benefit; attend all scheduled appointments; practice techniques between sessions for best outcomes",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE"
        }
      ],
      "Lifestyle & Prevention": [
        {
          "item": "Noise protection: Wear hearing protection in all environments >85 dB; use decibel-monitoring smartphone apps; limit headphone use to 60% volume for no more than 60 minutes at a time (60/60 rule)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Stress management: Chronic stress amplifies tinnitus perception; engage in regular mindfulness, meditation, or relaxation exercises; referral to psychologist or CBT therapist for tinnitus-specific coping strategies",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE"
        },
        {
          "item": "Sleep hygiene: Maintain consistent sleep-wake schedule; use sound enrichment at bedtime (white noise, nature sounds); avoid screens 1 hour before bed; melatonin 3-5 mg if persistent insomnia; CBT-I referral for chronic insomnia",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Cardiovascular health: Regular moderate-intensity exercise (150 min/week); optimize blood pressure, lipids, glucose; vascular risk factors worsen both pulsatile and non-pulsatile tinnitus",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE"
        },
        {
          "item": "Avoid ototoxic substances: Read medication labels; ask pharmacist about ototoxicity with new prescriptions; avoid prolonged NSAID use; report any new tinnitus to prescribing physician",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        }
      ]
    }
  },
  "differential": [
    {
      "diagnosis": "Type",
      "features": "Description",
      "tests": "Common Causes"
    },
    {
      "diagnosis": "**Subjective non-pulsatile**",
      "features": "Perceived by patient only; continuous or intermittent ringing, buzzing, hissing; most common type (~85% of tinnitus)",
      "tests": "Noise-induced hearing loss, presbycusis, ototoxic medications, Meniere's disease, vestibular schwannoma, idiopathic"
    },
    {
      "diagnosis": "**Subjective pulsatile**",
      "features": "Perceived by patient only; rhythmic, pulse-synchronous (heartbeat-like); ~5% of tinnitus but HIGH yield for treatable pathology",
      "tests": "IIH, dural AVF, carotid stenosis/dissection, transverse sinus stenosis, anemia, hyperthyroidism, glomus tumor"
    },
    {
      "diagnosis": "**Objective pulsatile**",
      "features": "Audible to examiner (stethoscope over ear/mastoid); vascular or mechanical source",
      "tests": "Dural AVF, glomus tumor, carotid stenosis, aberrant carotid artery, venous hum, arteriovenous malformation"
    },
    {
      "diagnosis": "**Objective non-pulsatile**",
      "features": "Audible clicking/crackling; rare",
      "tests": "Palatal myoclonus, stapedial muscle spasm, patulous Eustachian tube, TMJ crepitus"
    }
  ],
  "evidence": [
    {
      "recommendation": "Guideline",
      "evidenceLevel": "Source",
      "source": "Year"
    },
    {
      "recommendation": "Clinical Practice Guideline: Tinnitus",
      "evidenceLevel": "[AAO-HNS (Tunkel et al.)](https://pubmed.ncbi.nlm.nih.gov/25348604/)",
      "source": "2014"
    },
    {
      "recommendation": "Diagnostic Approach to Pulsatile Tinnitus",
      "evidenceLevel": "[Defined diagnostic algorithm](https://pubmed.ncbi.nlm.nih.gov/23910692/)",
      "source": "2013"
    },
    {
      "recommendation": "Sudden Sensorineural Hearing Loss Practice Guideline",
      "evidenceLevel": "[AAO-HNS (Chandrasekhar et al.)](https://pubmed.ncbi.nlm.nih.gov/31369359/)",
      "source": "2019"
    },
    {
      "recommendation": "European Guideline on Tinnitus",
      "evidenceLevel": "[European Academy of Otology and Neurotology](https://pubmed.ncbi.nlm.nih.gov/30847727/)",
      "source": "2019"
    },
    {
      "recommendation": "Study",
      "evidenceLevel": "Finding",
      "source": "Impact"
    },
    {
      "recommendation": "[Cima et al. (2012)](https://pubmed.ncbi.nlm.nih.gov/22927685/)",
      "evidenceLevel": "Stepped-care CBT for tinnitus significantly reduced tinnitus-related distress, improved quality of life in randomized controlled trial (n=492)",
      "source": "CBT is the most evidence-supported therapy for tinnitus; first-line for bothersome chronic tinnitus"
    },
    {
      "recommendation": "[Langguth et al. (2012)](https://pubmed.ncbi.nlm.nih.gov/22363816/)",
      "evidenceLevel": "Systematic review of rTMS for tinnitus; moderate short-term benefit on tinnitus severity; optimal stimulation parameters not established",
      "source": "TMS is promising but not yet standard; reserved for refractory cases in research settings"
    },
    {
      "recommendation": "[Mattox & Simmons (1977)](https://pubmed.ncbi.nlm.nih.gov/559939/)",
      "evidenceLevel": "Natural history of vestibular schwannoma: tinnitus is presenting symptom in ~70% of patients; often precedes hearing loss",
      "source": "Unilateral tinnitus warrants MRI to rule out vestibular schwannoma"
    },
    {
      "recommendation": "[Sismanis (2003)](https://pubmed.ncbi.nlm.nih.gov/12544033/)",
      "evidenceLevel": "Comprehensive review of pulsatile tinnitus etiologies; defined diagnostic algorithm; dural AVF is most common surgically treatable vascular cause",
      "source": "Pulsatile tinnitus requires systematic vascular evaluation; high rate of identifiable and treatable pathology"
    },
    {
      "recommendation": "[Bauer & Brozoski (2006)](https://pubmed.ncbi.nlm.nih.gov/16413413/)",
      "evidenceLevel": "Gabapentin showed modest benefit for tinnitus related to acoustic trauma in RCT; no benefit in non-trauma tinnitus",
      "source": "Gabapentin helps trauma-related tinnitus but is not effective for non-traumatic tinnitus"
    },
    {
      "recommendation": "[Sullivan et al. (1993)](https://pubmed.ncbi.nlm.nih.gov/8437846/)",
      "evidenceLevel": "Nortriptyline reduced tinnitus loudness and depression in patients with severe tinnitus and comorbid depression",
      "source": "Tricyclic antidepressants benefit tinnitus patients with depression; treat comorbidity"
    },
    {
      "recommendation": "[NORDIC IIH Study Group (2014)](https://pubmed.ncbi.nlm.nih.gov/24687293/)",
      "evidenceLevel": "Acetazolamide with diet significantly improved papilledema, visual function, headache, pulsatile tinnitus, and quality of life in IIH (n=165)",
      "source": "Acetazolamide is first-line medical therapy for IIH; pulsatile tinnitus improves with ICP reduction"
    },
    {
      "recommendation": "[Chandrasekhar et al. (2019)](https://pubmed.ncbi.nlm.nih.gov/31369359/)",
      "evidenceLevel": "AAO-HNS guideline for sudden SNHL: steroids recommended within 2 weeks; intratympanic salvage if systemic fails; MRI to rule out retrocochlear",
      "source": "Standard of care for sudden hearing loss with tinnitus; early treatment improves outcomes"
    },
    {
      "recommendation": "Tool",
      "evidenceLevel": "Scoring",
      "source": "Clinical Utility"
    },
    {
      "recommendation": "Tinnitus Functional Index (TFI)",
      "evidenceLevel": "0-100; <25 mild, 25-50 significant, >50 severe, >75 catastrophic",
      "source": "Most sensitive to treatment change; validated; tracks longitudinal response"
    },
    {
      "recommendation": "Tinnitus Handicap Inventory (THI)",
      "evidenceLevel": "0-100; Grade 1 (0-16) to Grade 5 (78-100)",
      "source": "Widely used; good test-retest reliability; validated in multiple languages"
    },
    {
      "recommendation": "Visual Analogue Scale (VAS) for tinnitus",
      "evidenceLevel": "0-10 for loudness and annoyance",
      "source": "Quick; useful for serial tracking; less comprehensive"
    }
  ],
  "monitoring": [
    {
      "item": "Neurologic exam (cranial nerves, fundoscopy, hearing)",
      "ED": "STAT",
      "HOSP": "STAT",
      "OPD": "ROUTINE",
      "ICU": "-",
      "frequency": "On presentation",
      "target": "No focal deficits; no papilledema",
      "action": "Papilledema — urgent MRI/MRV/LP; focal deficits — STAT MRI; cranial bruit — vascular imaging"
    },
    {
      "item": "Vital signs",
      "ED": "STAT",
      "HOSP": "ROUTINE",
      "OPD": "-",
      "ICU": "-",
      "frequency": "q4h (if admitted); on presentation (ED)",
      "target": "Stable; no hypertensive crisis",
      "action": "Hypertension — manage per guidelines; tachycardia — evaluate thyroid, anemia"
    },
    {
      "item": "Hearing assessment (bedside)",
      "ED": "STAT",
      "HOSP": "STAT",
      "OPD": "ROUTINE",
      "ICU": "-",
      "frequency": "On presentation",
      "target": "Weber/Rinne normal or lateralizes appropriately",
      "action": "Asymmetry — urgent audiometry; sudden SNHL — start steroids"
    },
    {
      "item": "Tinnitus characterization",
      "ED": "STAT",
      "HOSP": "STAT",
      "OPD": "ROUTINE",
      "ICU": "-",
      "frequency": "On presentation",
      "target": "Document pulsatile vs. non-pulsatile; unilateral vs. bilateral; quality; duration; modulating factors",
      "action": "Pulsatile — vascular imaging pathway; unilateral — MRI pathway"
    },
    {
      "item": "Blood glucose (if on steroids)",
      "ED": "STAT",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-",
      "frequency": "Every 6 hours while on steroids",
      "target": "Glucose <200 mg/dL",
      "action": "Glucose >200 — insulin per sliding scale; endocrine consultation if persistent"
    }
  ],
  "disposition": [
    {
      "disposition": "Level of Care",
      "criteria": "Criteria"
    },
    {
      "disposition": "ICU",
      "criteria": "Hemorrhagic complication of dural AVF (intracranial hemorrhage); acute stroke from carotid dissection; severe IIH with visual loss requiring emergent intervention"
    },
    {
      "disposition": "General floor",
      "criteria": "Sudden sensorineural hearing loss requiring IV steroids and monitoring; newly diagnosed cerebral venous sinus thrombosis requiring anticoagulation initiation; newly diagnosed dural AVF requiring observation and planning for intervention; IIH with significant papilledema requiring serial visual field assessments and LP"
    },
    {
      "disposition": "Observation",
      "criteria": "Diagnostic uncertainty requiring urgent imaging (MRI/MRA not available as outpatient in timely fashion); intractable symptoms requiring symptomatic management"
    }
  ]
}